AAAAAA

   
Results: 1-18 |
Results: 18
IN-VITRO CARBOPLATIN-MESNA INTERACTION IN AQUEOUS-SOLUTION, HUMAN PLASMA AND URINE
Authors: OBROCEA MM NASSIM MA MOLEPO MJ SHIRAZI FH GALLANT G DULUDE H VINCENT MD STEWART DJ GOEL R
Citation: Mm. Obrocea et al., IN-VITRO CARBOPLATIN-MESNA INTERACTION IN AQUEOUS-SOLUTION, HUMAN PLASMA AND URINE, Oncology Reports, 5(6), 1998, pp. 1493-1498
A PHASE-I TRIAL OF HIGH-DOSE PACLITAXEL, CYCLOPHOSPHAMIDE AND MITOXANTRONE WITH AUTOLOGOUS BLOOD STEM-CELL SUPPORT FOR THE TREATMENT OF METASTATIC BREAST-CANCER
Authors: GLUCK S GERMOND C LOPEZ P CANO P DORREEN M KOSKI T ARNOLD A DULUDE H GALLANT G
Citation: S. Gluck et al., A PHASE-I TRIAL OF HIGH-DOSE PACLITAXEL, CYCLOPHOSPHAMIDE AND MITOXANTRONE WITH AUTOLOGOUS BLOOD STEM-CELL SUPPORT FOR THE TREATMENT OF METASTATIC BREAST-CANCER, European journal of cancer, 34(7), 1998, pp. 1008-1014
REMISSION INDUCTION THERAPY OF UNTREATED ACUTE MYELOID-LEUKEMIA USINGA NON-CYTARABINE-CONTAINING REGIMEN OF IDARUBICIN, ETOPOSIDE, AND CARBOPLATIN
Authors: BOW EJ GALLANT G WILLIAMS GJ WOLOSCHUK D SHORE TB RUBINGER M SCHACTER BA
Citation: Ej. Bow et al., REMISSION INDUCTION THERAPY OF UNTREATED ACUTE MYELOID-LEUKEMIA USINGA NON-CYTARABINE-CONTAINING REGIMEN OF IDARUBICIN, ETOPOSIDE, AND CARBOPLATIN, Cancer, 83(7), 1998, pp. 1344-1354
A MULTICENTER PHASE-II STUDY OF CARBOPLATIN AND PROLONGED ORAL ETOPOSIDE IN THE TREATMENT OF CANCER OF UNKNOWN PRIMARY SITE (CUPS)
Authors: WARNER E GOEL R CHANG J CHOW W VERMA S DANCEY J FRANSSEN E DULUDE H GIROUARD M CORREIA J GALLANT G
Citation: E. Warner et al., A MULTICENTER PHASE-II STUDY OF CARBOPLATIN AND PROLONGED ORAL ETOPOSIDE IN THE TREATMENT OF CANCER OF UNKNOWN PRIMARY SITE (CUPS), British Journal of Cancer, 77(12), 1998, pp. 2376-2380
CONCURRENT USE OF MULTIPLE CHEMOTHERAPY RESISTANCE MODULATORS WITH ETOPOSIDE IN PATIENTS WITH RESISTANT MALIGNANCIES
Authors: STEWART DJ GOEL R CRIPPS MC YAU J HUAN S TOMIAK E DAVIES RA DULUDE H GALLANT G
Citation: Dj. Stewart et al., CONCURRENT USE OF MULTIPLE CHEMOTHERAPY RESISTANCE MODULATORS WITH ETOPOSIDE IN PATIENTS WITH RESISTANT MALIGNANCIES, International journal of oncology, 11(4), 1997, pp. 709-716
TAXOL(TM) (PACLITAXEL), EPIRUBICIN AND CYCLOPHOSPHAMIDE (TEC) IN THE TREATMENT OF METASTATIC BREAST-CANCER (MBC) - RESULTS OF A PHASE-I STUDY
Authors: NABHOLTZ JM KHOO K MACKEY JR SMYLIE M ALTWEGIERI T DUDGEON D KELLER O FOERSTER O OLWENY C SHORE T SANSREGRET E STILES E DULUDE H GALLANT G BROWN B
Citation: Jm. Nabholtz et al., TAXOL(TM) (PACLITAXEL), EPIRUBICIN AND CYCLOPHOSPHAMIDE (TEC) IN THE TREATMENT OF METASTATIC BREAST-CANCER (MBC) - RESULTS OF A PHASE-I STUDY, Breast, 6(5), 1997, pp. 320-320
TAXOL(TM) (PACLITAXEL), EPIRUBICIN AND CYCLOPHOSPHAMIDE (TEC) IN THE TREATMENT OF METASTATIC BREAST-CANCER (MBC) - RESULTS OF A PHASE-I STUDY
Authors: NABHOLTZ JM KHOO K MACKEY JR SMYLIE M ALTWEIGERI T DUDGEON D KELLER O FOERSTER O OLWENY C SHORE T SANSREGRET E STILES E DULUDE H GALLANT G BROWN B
Citation: Jm. Nabholtz et al., TAXOL(TM) (PACLITAXEL), EPIRUBICIN AND CYCLOPHOSPHAMIDE (TEC) IN THE TREATMENT OF METASTATIC BREAST-CANCER (MBC) - RESULTS OF A PHASE-I STUDY, European journal of cancer, 33, 1997, pp. 678-678
ETOPOSIDE AND DOXORUBICIN ANTAGONIZE THE IN-VITRO ACTIVITY OF PACLITAXEL IN HUMAN NONSMALL CELL LUNG-CANCER CELL-LINES
Authors: VIALLET J TSAO MS GALLANT G
Citation: J. Viallet et al., ETOPOSIDE AND DOXORUBICIN ANTAGONIZE THE IN-VITRO ACTIVITY OF PACLITAXEL IN HUMAN NONSMALL CELL LUNG-CANCER CELL-LINES, Lung cancer, 15(1), 1996, pp. 93-101
SYNTHESIS AND IN-VITRO ANTI-HIV AND ANTITUMOR-ACTIVITY OF NEW 2-CHLOROETHYL THIOCARBAMATES
Authors: GALLANT G SALVADOR R DULUDE H
Citation: G. Gallant et al., SYNTHESIS AND IN-VITRO ANTI-HIV AND ANTITUMOR-ACTIVITY OF NEW 2-CHLOROETHYL THIOCARBAMATES, Bioorganic & medicinal chemistry letters, 5(14), 1995, pp. 1523-1526
A MULTICENTER, RANDOMIZED STUDY OF 2 SCHEDULES OF PACLITAXEL (PTX) INPATIENTS WITH ADVANCED BREAST-CANCER (ABC)
Authors: PERETZ T SULKES A CHOLLET P GELMON K PARIDAENS R GORBONUVA V CATIMEL G KUHNLE H HUININK WTB KHAYAT D DITTRICH C KLAASSEN U BERGH J WILKING N NABHOLTZ JM CALABRESI F TUBIANAHULIN M CHAZARD M GALLANT G DIERGARTEN K WESTBERG R BOGAERT J RENARD J WEIL C
Citation: T. Peretz et al., A MULTICENTER, RANDOMIZED STUDY OF 2 SCHEDULES OF PACLITAXEL (PTX) INPATIENTS WITH ADVANCED BREAST-CANCER (ABC), European journal of cancer, 31A, 1995, pp. 345-345
IN-VITRO CYTOTOXICITY AND DIFFERENTIAL CELLULAR-SENSITIVITY OF DERIVATIVES OF DIAMINO ACIDS .1. N-1-METHYL, N-1-ALLYL, N-1-(2-CHLOROETHYL) AND N-1-PROPARGYL UREAS
Authors: DULUDE H SALVADOR R GALLANT G
Citation: H. Dulude et al., IN-VITRO CYTOTOXICITY AND DIFFERENTIAL CELLULAR-SENSITIVITY OF DERIVATIVES OF DIAMINO ACIDS .1. N-1-METHYL, N-1-ALLYL, N-1-(2-CHLOROETHYL) AND N-1-PROPARGYL UREAS, Anticancer research, 15(3), 1995, pp. 847-852
IN-VITRO CYTOTOXICITY AND DIFFERENTIAL CELLULAR-SENSITIVITY OF DERIVATIVES OF DIAMINO ACIDS .2. N-1-METHYL, N-1-ALLYL, N-1-(2-CHLOROETHYL) AND N-1-PROPARGYL NITROSOUREAS
Authors: DULUDE H SALVADOR R GALLANT G
Citation: H. Dulude et al., IN-VITRO CYTOTOXICITY AND DIFFERENTIAL CELLULAR-SENSITIVITY OF DERIVATIVES OF DIAMINO ACIDS .2. N-1-METHYL, N-1-ALLYL, N-1-(2-CHLOROETHYL) AND N-1-PROPARGYL NITROSOUREAS, Anticancer research, 15(3), 1995, pp. 853-858
CHEMICAL-STABILITY OF NEW UREA AND NITROSOUREA DERIVATIVES OF DIAMINOACIDS
Authors: DULUDE H SALVADOR R GALLANT G
Citation: H. Dulude et al., CHEMICAL-STABILITY OF NEW UREA AND NITROSOUREA DERIVATIVES OF DIAMINOACIDS, Bioorganic & medicinal chemistry letters, 4(22), 1994, pp. 2697-2700
SYNTHESIS, CHEMICAL HALF-LIFE AND DECOMPOSITION OF NEW N-3-(SUBSTITUTED) DERIVATIVES OF CCNU
Authors: GALLANT G SALVADOR R DULUDE H
Citation: G. Gallant et al., SYNTHESIS, CHEMICAL HALF-LIFE AND DECOMPOSITION OF NEW N-3-(SUBSTITUTED) DERIVATIVES OF CCNU, Bioorganic & medicinal chemistry letters, 4(19), 1994, pp. 2353-2358
RESETTLEMENT WITHOUT THE SUPPORT OF AN ETHNOCULTURAL COMMUNITY
Authors: BAKER C ARSENEAULT AM GALLANT G
Citation: C. Baker et al., RESETTLEMENT WITHOUT THE SUPPORT OF AN ETHNOCULTURAL COMMUNITY, Journal of advanced nursing, 20(6), 1994, pp. 1064-1072
SYNTHESIS AND PRELIMINARY IN-VITRO CYTOTOXICITY EVALUATION OF 1,3-BIS-(2-PROPYNYL)-1-NITROSOUREA (BPNU) AND DERIVATIVES
Authors: GALLANT G SALVADOR R DULUDE H
Citation: G. Gallant et al., SYNTHESIS AND PRELIMINARY IN-VITRO CYTOTOXICITY EVALUATION OF 1,3-BIS-(2-PROPYNYL)-1-NITROSOUREA (BPNU) AND DERIVATIVES, Anticancer research, 14(6B), 1994, pp. 2695-2699
IN-VITRO EFFECT OF PACLITAXEL IN COMBINATION WITH CYTOTOXIC AGENTS ON2 DIFFERENT HUMAN MYELOMA CELL-LINES
Authors: WILSON C KOSTER W DIETZ G CHADDERTON T LUTYNSKI A SHARAN N GALLANT G DULUDE H GLUCK S
Citation: C. Wilson et al., IN-VITRO EFFECT OF PACLITAXEL IN COMBINATION WITH CYTOTOXIC AGENTS ON2 DIFFERENT HUMAN MYELOMA CELL-LINES, Blood, 84(10), 1994, pp. 10000182-10000182
INVITRO CYTOTOXICITY AND DIFFERENTIAL CELLULAR-SENSITIVITY OF NEW N-METHYL AND N-PROPARGYL UREA AND NITROSOUREA DERIVATIVES OF DIAMINO ACIDS AGAINST 60 HUMAN NCI TUMOR-CELL LINES
Authors: GALLANT G SALVADOR R DULUDE H
Citation: G. Gallant et al., INVITRO CYTOTOXICITY AND DIFFERENTIAL CELLULAR-SENSITIVITY OF NEW N-METHYL AND N-PROPARGYL UREA AND NITROSOUREA DERIVATIVES OF DIAMINO ACIDS AGAINST 60 HUMAN NCI TUMOR-CELL LINES, Anticancer research, 13(1), 1993, pp. 133-140
Risultati: 1-18 |